Arrowhead Common Stock Total Equity from 2010 to 2024

ARWR Stock  USD 24.88  0.21  0.85%   
Arrowhead Pharmaceuticals Common Stock Total Equity yearly trend continues to be relatively stable with very little volatility. Common Stock Total Equity is likely to grow to about 239.1 K this year. Common Stock Total Equity is the total value of common stock equity held by shareholders, representing their ownership interest in the company. View All Fundamentals
 
Common Stock Total Equity  
First Reported
1999-12-31
Previous Quarter
199 K
Current Value
199 K
Quarterly Volatility
73.7 K
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Arrowhead Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arrowhead main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.1 M, Interest Expense of 20 M or Selling General Administrative of 79.1 M, as well as many exotic indicators such as Price To Sales Ratio of 10.19, Dividend Yield of 0.0 or PTB Ratio of 4.8. Arrowhead financial statements analysis is a perfect complement when working with Arrowhead Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Arrowhead Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Arrowhead Pharmaceuticals Technical models . Check out the analysis of Arrowhead Pharmaceuticals Correlation against competitors.
To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.

Latest Arrowhead Pharmaceuticals' Common Stock Total Equity Growth Pattern

Below is the plot of the Common Stock Total Equity of Arrowhead Pharmaceuticals over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Arrowhead Pharmaceuticals' Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arrowhead Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Common Stock Total Equity10 Years Trend
Slightly volatile
   Common Stock Total Equity   
       Timeline  

Arrowhead Common Stock Total Equity Regression Statistics

Arithmetic Mean165,860
Geometric Mean133,077
Coefficient Of Variation34.48
Mean Deviation39,693
Median180,875
Standard Deviation57,184
Sample Variance3.3B
Range235.9K
R-Value0.88
Mean Square Error781.4M
R-Squared0.78
Significance0.000014
Slope11,279
Total Sum of Squares45.8B

Arrowhead Common Stock Total Equity History

2024239.1 K
2023227.7 K
2021198 K
2020197 K
2019194.7 K
2018187.9 K
2017180.9 K

About Arrowhead Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Arrowhead Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Arrowhead Pharmaceuticals investors use historical funamental indicators, such as Arrowhead Pharmaceuticals's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Although Arrowhead Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Arrowhead Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Arrowhead Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Arrowhead Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Arrowhead Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Total Equity227.7 K239.1 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Arrowhead Pharmaceuticals is a strong investment it is important to analyze Arrowhead Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Arrowhead Pharmaceuticals' future performance. For an informed investment choice regarding Arrowhead Stock, refer to the following important reports:
Check out the analysis of Arrowhead Pharmaceuticals Correlation against competitors.
To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Arrowhead Stock analysis

When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Money Managers
Screen money managers from public funds and ETFs managed around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Is Arrowhead Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharmaceuticals. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.098
Earnings Share
(4.23)
Revenue Per Share
0.319
Quarterly Revenue Growth
(0.94)
Return On Assets
(0.32)
The market value of Arrowhead Pharmaceuticals is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharmaceuticals' market value can be influenced by many factors that don't directly affect Arrowhead Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arrowhead Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.